Annalisa Schirizzi

Variations in Circulating Levels of Angiopoietin-2 Over Time Are Predictive of Ramucirumab–Paclitaxel Therapy Outcome in Advanced Gastric Cancer: Results of Prospective Study

G. Giannelli, R. D'Alessandro, M. G. Refolo, 2022, Frontiers in Oncology.

Insights into the molecular pathogenesis of cardiospondylocarpofacial syndrome: MAP3K7 c.737-7A > G variant alters the TGFβ-mediated α-SMA cytoskeleton assembly and autophagy.

T. Mazza, G. Mazzoccoli, L. Micale, 2020, Biochimica et biophysica acta. Molecular basis of disease.

Exon-Trapping Assay Improves Clinical Interpretation of COL11A1 and COL11A2 Intronic Variants in Stickler Syndrome Type 2 and Otospondylomegaepiphyseal Dysplasia

S. Castellana, L. Micale, C. Fusco, 2020, Genes.

The multiple combination of Paclitaxel, Ramucirumab and Elacridar reverses the paclitaxel-mediated resistance in gastric cancer cell lines

G. Giannelli, J. Kopecka, C. Riganti, 2023, Frontiers in Oncology.

Targeting Angiogenesis in the Era of Biliary Tract Cancer Immunotherapy: Biological Rationale, Clinical Implications, and Future Research Avenues

G. Giannelli, R. D'Alessandro, A. Ricci, 2023, Cancers.